Loading…
Coinfections with SARS‐CoV‐2 variants and influenza virus during the 2019 Coronavirus disease pandemic in Burkina Faso: A surveillance study
Background and Aim Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) particularly the variants of concern coinfections with influenza is a public health concern in Africa. We aimed to characterize the SARS‐CoV‐2 variants and determine the rate of coinfections with influenza in Burkina Fas...
Saved in:
Published in: | Health science reports 2023-01, Vol.6 (1), p.e1041-n/a |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c5091-afbf1e1e60a8e08ed5fa3634e95296539bcf0bf1808f040464d4f5d70fb31e103 |
---|---|
cites | cdi_FETCH-LOGICAL-c5091-afbf1e1e60a8e08ed5fa3634e95296539bcf0bf1808f040464d4f5d70fb31e103 |
container_end_page | n/a |
container_issue | 1 |
container_start_page | e1041 |
container_title | Health science reports |
container_volume | 6 |
creator | Lingani, Moussa Cissé, Assana Tialla, Dieudonné Ilboudo, Abdoul Kader Savadogo, Madi Sawadogo, Catherine Gampini, Sandrine Tarnagda, Grissoum Tao, Maria Diagbouga, Serge Bamba, Sanata Tarnagda, Zekiba |
description | Background and Aim
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) particularly the variants of concern coinfections with influenza is a public health concern in Africa. We aimed to characterize the SARS‐CoV‐2 variants and determine the rate of coinfections with influenza in Burkina Faso.
Methods
COVID‐19 surveillance study was conducted between August 2021 and January 2022 using reverse transcription polymerase chain reaction (RT‐PCR). Positive specimens were further screened for SARS‐CoV‐2 variants using the multiple variants real‐time PCR kits. In addition, influenza virus strains were detected by RT‐PCR in SARS‐CoV‐2 positive specimens using the CDC primers, probes, and protocols.
Results
Of 324 specimens assessed, the Omicron and Delta variants of SARS‐CoV‐2 were the most prevalent with 27.2% [95% confident interval (CI): 22.5–32.4] and 22.2% [95% CI: 17.9–27.2], respectively. The Beta and Gamma variants were detected in 4.3% [95% CI: 2.4–7.1] and 0.3% [95% CI: 0.0–1.7], respectively. Coinfections of Omicron and Beta variants were reported in 21.3% [95% CI: 17.0–26.2], Omicron and Delta variants in 1.2% [95% CI: 0.3–3.1] of specimens, and the Omicron–Gamma variants' coinfections in 0.6% [95% CI: 0.1–2.2]. One COVID‐19 specimen with an undetected SARS‐CoV‐2 variant was also tested positive for the seasonal influenza A (H3N2) virus. No cases of pandemic influenza A (H1N1)pdm09, seasonal A/H1N1, and influenza B were detected.
Conclusions
The current World Health Organization SARS‐CoV‐2 variants of concern were prevalent and their coinfections with influenza were uncommon. Continuous surveillance of both pathogens is, however, needed because of their public health implications. |
doi_str_mv | 10.1002/hsr2.1041 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_458f8bec8db64245ab6e03fe776e7dfb</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_458f8bec8db64245ab6e03fe776e7dfb</doaj_id><sourcerecordid>2762819449</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5091-afbf1e1e60a8e08ed5fa3634e95296539bcf0bf1808f040464d4f5d70fb31e103</originalsourceid><addsrcrecordid>eNp1ksFuEzEQhi0EolXogRdAlrjAIdT2er02B6QQUVqpElILXC3v7jhx2NjB3k0VTjwCz8iT4G1C1SJxsUcz3_wa_foRek7JG0oIO12myHLF6SN0zAolp1IW5eN79RE6SWlFMksYL6V6io4KIRgpKTlGv-bBeQtN74JP-Mb1S3w9u7r-_TMPvuaX4a2Jzvg-YeNbnNluAP_D4K2LQ8LtEJ1f4H4JmBGq8DzE4M1h5hKYBHiTF2HtmryM3w_xm_MGn5kU3uIZTkPcgus64xvAqR_a3TP0xJouwcnhn6AvZx8-z8-nl58-Xsxnl9OmJIpOja0tBQqCGAlEQltaU4iCgyqZEmWh6saSjEgiLeGEC95yW7YVsXWR90gxQRd73TaYld5EtzZxp4Nx-rYR4kKb2LumA51Ns7KGRra14NlCUwsghYWqElC1WXCC3u21NkO9hrYB30fTPRB9OPFuqRdhq5WktODjMa8OAjF8HyD1eu1SA6MvEIakWSWYpIpzldGX_6CrMESfrRopqcpKiJF6vaeaGFKKYO-OoUSPsdFjbPQYm8y-uH_9Hfk3JBk43QM3roPd_5X0-fUVu5X8A1BGz4s</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2768957669</pqid></control><display><type>article</type><title>Coinfections with SARS‐CoV‐2 variants and influenza virus during the 2019 Coronavirus disease pandemic in Burkina Faso: A surveillance study</title><source>Open Access: Wiley-Blackwell Open Access Journals</source><source>Publicly Available Content (ProQuest)</source><source>PubMed Central</source><source>Coronavirus Research Database</source><creator>Lingani, Moussa ; Cissé, Assana ; Tialla, Dieudonné ; Ilboudo, Abdoul Kader ; Savadogo, Madi ; Sawadogo, Catherine ; Gampini, Sandrine ; Tarnagda, Grissoum ; Tao, Maria ; Diagbouga, Serge ; Bamba, Sanata ; Tarnagda, Zekiba</creator><creatorcontrib>Lingani, Moussa ; Cissé, Assana ; Tialla, Dieudonné ; Ilboudo, Abdoul Kader ; Savadogo, Madi ; Sawadogo, Catherine ; Gampini, Sandrine ; Tarnagda, Grissoum ; Tao, Maria ; Diagbouga, Serge ; Bamba, Sanata ; Tarnagda, Zekiba</creatorcontrib><description>Background and Aim
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) particularly the variants of concern coinfections with influenza is a public health concern in Africa. We aimed to characterize the SARS‐CoV‐2 variants and determine the rate of coinfections with influenza in Burkina Faso.
Methods
COVID‐19 surveillance study was conducted between August 2021 and January 2022 using reverse transcription polymerase chain reaction (RT‐PCR). Positive specimens were further screened for SARS‐CoV‐2 variants using the multiple variants real‐time PCR kits. In addition, influenza virus strains were detected by RT‐PCR in SARS‐CoV‐2 positive specimens using the CDC primers, probes, and protocols.
Results
Of 324 specimens assessed, the Omicron and Delta variants of SARS‐CoV‐2 were the most prevalent with 27.2% [95% confident interval (CI): 22.5–32.4] and 22.2% [95% CI: 17.9–27.2], respectively. The Beta and Gamma variants were detected in 4.3% [95% CI: 2.4–7.1] and 0.3% [95% CI: 0.0–1.7], respectively. Coinfections of Omicron and Beta variants were reported in 21.3% [95% CI: 17.0–26.2], Omicron and Delta variants in 1.2% [95% CI: 0.3–3.1] of specimens, and the Omicron–Gamma variants' coinfections in 0.6% [95% CI: 0.1–2.2]. One COVID‐19 specimen with an undetected SARS‐CoV‐2 variant was also tested positive for the seasonal influenza A (H3N2) virus. No cases of pandemic influenza A (H1N1)pdm09, seasonal A/H1N1, and influenza B were detected.
Conclusions
The current World Health Organization SARS‐CoV‐2 variants of concern were prevalent and their coinfections with influenza were uncommon. Continuous surveillance of both pathogens is, however, needed because of their public health implications.</description><identifier>ISSN: 2398-8835</identifier><identifier>EISSN: 2398-8835</identifier><identifier>DOI: 10.1002/hsr2.1041</identifier><identifier>PMID: 36620510</identifier><language>eng</language><publisher>United States: John Wiley & Sons, Inc</publisher><subject>Airports ; Burkina Faso ; Coronaviruses ; COVID-19 vaccines ; COVID‐19 ; Disease prevention ; Health surveillance ; Infections ; Influenza ; Mutation ; Original Research ; Pandemics ; SARS‐CoV‐2 ; Severe acute respiratory syndrome coronavirus 2 ; Software ; Statistical analysis ; Thermal cycling ; variant ; Viral infections ; Viruses</subject><ispartof>Health science reports, 2023-01, Vol.6 (1), p.e1041-n/a</ispartof><rights>2023 The Authors. published by Wiley Periodicals LLC.</rights><rights>2023 The Authors. Health Science Reports published by Wiley Periodicals LLC.</rights><rights>2023. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5091-afbf1e1e60a8e08ed5fa3634e95296539bcf0bf1808f040464d4f5d70fb31e103</citedby><cites>FETCH-LOGICAL-c5091-afbf1e1e60a8e08ed5fa3634e95296539bcf0bf1808f040464d4f5d70fb31e103</cites><orcidid>0000-0002-5651-2035</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2768957669?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2768957669?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,11543,25733,27903,27904,36991,36992,38495,43874,44569,46030,46454,53769,53771,74158,74872</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36620510$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lingani, Moussa</creatorcontrib><creatorcontrib>Cissé, Assana</creatorcontrib><creatorcontrib>Tialla, Dieudonné</creatorcontrib><creatorcontrib>Ilboudo, Abdoul Kader</creatorcontrib><creatorcontrib>Savadogo, Madi</creatorcontrib><creatorcontrib>Sawadogo, Catherine</creatorcontrib><creatorcontrib>Gampini, Sandrine</creatorcontrib><creatorcontrib>Tarnagda, Grissoum</creatorcontrib><creatorcontrib>Tao, Maria</creatorcontrib><creatorcontrib>Diagbouga, Serge</creatorcontrib><creatorcontrib>Bamba, Sanata</creatorcontrib><creatorcontrib>Tarnagda, Zekiba</creatorcontrib><title>Coinfections with SARS‐CoV‐2 variants and influenza virus during the 2019 Coronavirus disease pandemic in Burkina Faso: A surveillance study</title><title>Health science reports</title><addtitle>Health Sci Rep</addtitle><description>Background and Aim
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) particularly the variants of concern coinfections with influenza is a public health concern in Africa. We aimed to characterize the SARS‐CoV‐2 variants and determine the rate of coinfections with influenza in Burkina Faso.
Methods
COVID‐19 surveillance study was conducted between August 2021 and January 2022 using reverse transcription polymerase chain reaction (RT‐PCR). Positive specimens were further screened for SARS‐CoV‐2 variants using the multiple variants real‐time PCR kits. In addition, influenza virus strains were detected by RT‐PCR in SARS‐CoV‐2 positive specimens using the CDC primers, probes, and protocols.
Results
Of 324 specimens assessed, the Omicron and Delta variants of SARS‐CoV‐2 were the most prevalent with 27.2% [95% confident interval (CI): 22.5–32.4] and 22.2% [95% CI: 17.9–27.2], respectively. The Beta and Gamma variants were detected in 4.3% [95% CI: 2.4–7.1] and 0.3% [95% CI: 0.0–1.7], respectively. Coinfections of Omicron and Beta variants were reported in 21.3% [95% CI: 17.0–26.2], Omicron and Delta variants in 1.2% [95% CI: 0.3–3.1] of specimens, and the Omicron–Gamma variants' coinfections in 0.6% [95% CI: 0.1–2.2]. One COVID‐19 specimen with an undetected SARS‐CoV‐2 variant was also tested positive for the seasonal influenza A (H3N2) virus. No cases of pandemic influenza A (H1N1)pdm09, seasonal A/H1N1, and influenza B were detected.
Conclusions
The current World Health Organization SARS‐CoV‐2 variants of concern were prevalent and their coinfections with influenza were uncommon. Continuous surveillance of both pathogens is, however, needed because of their public health implications.</description><subject>Airports</subject><subject>Burkina Faso</subject><subject>Coronaviruses</subject><subject>COVID-19 vaccines</subject><subject>COVID‐19</subject><subject>Disease prevention</subject><subject>Health surveillance</subject><subject>Infections</subject><subject>Influenza</subject><subject>Mutation</subject><subject>Original Research</subject><subject>Pandemics</subject><subject>SARS‐CoV‐2</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Software</subject><subject>Statistical analysis</subject><subject>Thermal cycling</subject><subject>variant</subject><subject>Viral infections</subject><subject>Viruses</subject><issn>2398-8835</issn><issn>2398-8835</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>COVID</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp1ksFuEzEQhi0EolXogRdAlrjAIdT2er02B6QQUVqpElILXC3v7jhx2NjB3k0VTjwCz8iT4G1C1SJxsUcz3_wa_foRek7JG0oIO12myHLF6SN0zAolp1IW5eN79RE6SWlFMksYL6V6io4KIRgpKTlGv-bBeQtN74JP-Mb1S3w9u7r-_TMPvuaX4a2Jzvg-YeNbnNluAP_D4K2LQ8LtEJ1f4H4JmBGq8DzE4M1h5hKYBHiTF2HtmryM3w_xm_MGn5kU3uIZTkPcgus64xvAqR_a3TP0xJouwcnhn6AvZx8-z8-nl58-Xsxnl9OmJIpOja0tBQqCGAlEQltaU4iCgyqZEmWh6saSjEgiLeGEC95yW7YVsXWR90gxQRd73TaYld5EtzZxp4Nx-rYR4kKb2LumA51Ns7KGRra14NlCUwsghYWqElC1WXCC3u21NkO9hrYB30fTPRB9OPFuqRdhq5WktODjMa8OAjF8HyD1eu1SA6MvEIakWSWYpIpzldGX_6CrMESfrRopqcpKiJF6vaeaGFKKYO-OoUSPsdFjbPQYm8y-uH_9Hfk3JBk43QM3roPd_5X0-fUVu5X8A1BGz4s</recordid><startdate>202301</startdate><enddate>202301</enddate><creator>Lingani, Moussa</creator><creator>Cissé, Assana</creator><creator>Tialla, Dieudonné</creator><creator>Ilboudo, Abdoul Kader</creator><creator>Savadogo, Madi</creator><creator>Sawadogo, Catherine</creator><creator>Gampini, Sandrine</creator><creator>Tarnagda, Grissoum</creator><creator>Tao, Maria</creator><creator>Diagbouga, Serge</creator><creator>Bamba, Sanata</creator><creator>Tarnagda, Zekiba</creator><general>John Wiley & Sons, Inc</general><general>John Wiley and Sons Inc</general><general>Wiley</general><scope>24P</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-5651-2035</orcidid></search><sort><creationdate>202301</creationdate><title>Coinfections with SARS‐CoV‐2 variants and influenza virus during the 2019 Coronavirus disease pandemic in Burkina Faso: A surveillance study</title><author>Lingani, Moussa ; Cissé, Assana ; Tialla, Dieudonné ; Ilboudo, Abdoul Kader ; Savadogo, Madi ; Sawadogo, Catherine ; Gampini, Sandrine ; Tarnagda, Grissoum ; Tao, Maria ; Diagbouga, Serge ; Bamba, Sanata ; Tarnagda, Zekiba</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5091-afbf1e1e60a8e08ed5fa3634e95296539bcf0bf1808f040464d4f5d70fb31e103</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Airports</topic><topic>Burkina Faso</topic><topic>Coronaviruses</topic><topic>COVID-19 vaccines</topic><topic>COVID‐19</topic><topic>Disease prevention</topic><topic>Health surveillance</topic><topic>Infections</topic><topic>Influenza</topic><topic>Mutation</topic><topic>Original Research</topic><topic>Pandemics</topic><topic>SARS‐CoV‐2</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Software</topic><topic>Statistical analysis</topic><topic>Thermal cycling</topic><topic>variant</topic><topic>Viral infections</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lingani, Moussa</creatorcontrib><creatorcontrib>Cissé, Assana</creatorcontrib><creatorcontrib>Tialla, Dieudonné</creatorcontrib><creatorcontrib>Ilboudo, Abdoul Kader</creatorcontrib><creatorcontrib>Savadogo, Madi</creatorcontrib><creatorcontrib>Sawadogo, Catherine</creatorcontrib><creatorcontrib>Gampini, Sandrine</creatorcontrib><creatorcontrib>Tarnagda, Grissoum</creatorcontrib><creatorcontrib>Tao, Maria</creatorcontrib><creatorcontrib>Diagbouga, Serge</creatorcontrib><creatorcontrib>Bamba, Sanata</creatorcontrib><creatorcontrib>Tarnagda, Zekiba</creatorcontrib><collection>Open Access: Wiley-Blackwell Open Access Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Health science reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lingani, Moussa</au><au>Cissé, Assana</au><au>Tialla, Dieudonné</au><au>Ilboudo, Abdoul Kader</au><au>Savadogo, Madi</au><au>Sawadogo, Catherine</au><au>Gampini, Sandrine</au><au>Tarnagda, Grissoum</au><au>Tao, Maria</au><au>Diagbouga, Serge</au><au>Bamba, Sanata</au><au>Tarnagda, Zekiba</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Coinfections with SARS‐CoV‐2 variants and influenza virus during the 2019 Coronavirus disease pandemic in Burkina Faso: A surveillance study</atitle><jtitle>Health science reports</jtitle><addtitle>Health Sci Rep</addtitle><date>2023-01</date><risdate>2023</risdate><volume>6</volume><issue>1</issue><spage>e1041</spage><epage>n/a</epage><pages>e1041-n/a</pages><issn>2398-8835</issn><eissn>2398-8835</eissn><abstract>Background and Aim
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) particularly the variants of concern coinfections with influenza is a public health concern in Africa. We aimed to characterize the SARS‐CoV‐2 variants and determine the rate of coinfections with influenza in Burkina Faso.
Methods
COVID‐19 surveillance study was conducted between August 2021 and January 2022 using reverse transcription polymerase chain reaction (RT‐PCR). Positive specimens were further screened for SARS‐CoV‐2 variants using the multiple variants real‐time PCR kits. In addition, influenza virus strains were detected by RT‐PCR in SARS‐CoV‐2 positive specimens using the CDC primers, probes, and protocols.
Results
Of 324 specimens assessed, the Omicron and Delta variants of SARS‐CoV‐2 were the most prevalent with 27.2% [95% confident interval (CI): 22.5–32.4] and 22.2% [95% CI: 17.9–27.2], respectively. The Beta and Gamma variants were detected in 4.3% [95% CI: 2.4–7.1] and 0.3% [95% CI: 0.0–1.7], respectively. Coinfections of Omicron and Beta variants were reported in 21.3% [95% CI: 17.0–26.2], Omicron and Delta variants in 1.2% [95% CI: 0.3–3.1] of specimens, and the Omicron–Gamma variants' coinfections in 0.6% [95% CI: 0.1–2.2]. One COVID‐19 specimen with an undetected SARS‐CoV‐2 variant was also tested positive for the seasonal influenza A (H3N2) virus. No cases of pandemic influenza A (H1N1)pdm09, seasonal A/H1N1, and influenza B were detected.
Conclusions
The current World Health Organization SARS‐CoV‐2 variants of concern were prevalent and their coinfections with influenza were uncommon. Continuous surveillance of both pathogens is, however, needed because of their public health implications.</abstract><cop>United States</cop><pub>John Wiley & Sons, Inc</pub><pmid>36620510</pmid><doi>10.1002/hsr2.1041</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-5651-2035</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2398-8835 |
ispartof | Health science reports, 2023-01, Vol.6 (1), p.e1041-n/a |
issn | 2398-8835 2398-8835 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_458f8bec8db64245ab6e03fe776e7dfb |
source | Open Access: Wiley-Blackwell Open Access Journals; Publicly Available Content (ProQuest); PubMed Central; Coronavirus Research Database |
subjects | Airports Burkina Faso Coronaviruses COVID-19 vaccines COVID‐19 Disease prevention Health surveillance Infections Influenza Mutation Original Research Pandemics SARS‐CoV‐2 Severe acute respiratory syndrome coronavirus 2 Software Statistical analysis Thermal cycling variant Viral infections Viruses |
title | Coinfections with SARS‐CoV‐2 variants and influenza virus during the 2019 Coronavirus disease pandemic in Burkina Faso: A surveillance study |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T02%3A36%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Coinfections%20with%20SARS%E2%80%90CoV%E2%80%902%20variants%20and%20influenza%20virus%20during%20the%202019%20Coronavirus%20disease%20pandemic%20in%20Burkina%20Faso:%20A%20surveillance%20study&rft.jtitle=Health%20science%20reports&rft.au=Lingani,%20Moussa&rft.date=2023-01&rft.volume=6&rft.issue=1&rft.spage=e1041&rft.epage=n/a&rft.pages=e1041-n/a&rft.issn=2398-8835&rft.eissn=2398-8835&rft_id=info:doi/10.1002/hsr2.1041&rft_dat=%3Cproquest_doaj_%3E2762819449%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5091-afbf1e1e60a8e08ed5fa3634e95296539bcf0bf1808f040464d4f5d70fb31e103%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2768957669&rft_id=info:pmid/36620510&rfr_iscdi=true |